{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:52:20Z","timestamp":1777884740515,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015496","name":"Center for Networked Biomedical Research on Neurodegenerative Diseases","doi-asserted-by":"publisher","award":["CB18\/05\/00040"],"award-info":[{"award-number":["CB18\/05\/00040"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FPU20\/03743"],"award-info":[{"award-number":["FPU20\/03743"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","award":["HR21-00931"],"award-info":[{"award-number":["HR21-00931"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nbd.2025.106871","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:29:09Z","timestamp":1742066949000},"page":"106871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers"],"prefix":"10.1016","volume":"208","author":[{"given":"Eva P.","family":"Cuevas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Madruga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Valenzuela-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siranjeevi","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles","family":"Martin-Requero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2025.106871_bb0005","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s12035-021-02686-2","article-title":"piRNA\/PIWI protein complex as a potential biomarker in sporadic amyotrophic lateral sclerosis","volume":"59","author":"Abdelhamid","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.nbd.2025.106871_bb0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/awae028","article-title":"Brain cholesterol and Alzheimer\u2019s disease: challenges and opportunities in probe and drug development","volume":"147","author":"Ahmed","year":"2024","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nbd.2025.106871_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae268","article-title":"A microRNA diagnostic biomarker for amyotrophic lateral sclerosis","volume":"6","author":"Banack","year":"2024","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/s12864-021-08071-6","article-title":"piRNA-IPdb: a PIWI-bound piRNAs database to mining NGS sncRNA data and beyond","volume":"22","author":"Barre\u00f1ada","year":"2021","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0025","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1038\/s41598-023-40879-y","article-title":"miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis","volume":"13","author":"Cheng","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.nbd.2025.106871_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J. Intern. Med."},{"issue":"D1","key":"10.1016\/j.nbd.2025.106871_bb0035","doi-asserted-by":"crossref","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0040","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1038\/s41598-022-23985-1","article-title":"High-throughput transcriptomics","volume":"12","author":"D\u2019Agostino","year":"2022","journal-title":"Sci. Rep."},{"issue":"3\u20134","key":"10.1016\/j.nbd.2025.106871_bb0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/21678421.2023.2285443","article-title":"Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning","volume":"25","author":"Din Abdul Jabbar","year":"2024","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1016\/j.nbd.2025.106871_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117502","article-title":"Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients","volume":"392","author":"Escate","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nbd.2025.106871_bb0055","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01368","article-title":"Modulation of mitochondria-endoplasmic reticulum contacts (MERCs) by small molecules as a new strategy for restoring lipid metabolism in an amyotrophic lateral sclerosis model","author":"Etxebeste-Mitxeltorena","year":"2025","journal-title":"J. Med. Chem."},{"issue":"10360","key":"10.1016\/j.nbd.2025.106871_bb0060","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.nbd.2025.106871_bb0065","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1111\/febs.16175","article-title":"Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon?","volume":"289","author":"Hartmann","year":"2022","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.nbd.2025.106871_bb0070","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/bph.15224","article-title":"Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis","volume":"178","author":"Herrando-Grabulosa","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/neup.12153","article-title":"Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions","volume":"35","author":"Honda","year":"2015","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2025.106871_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pediatrneurol.2020.08.001","article-title":"A phase 2 study of AMO-02 (Tideglusib) in congenital and childhood-onset myotonic dystrophy type 1 (DM1)","volume":"112","author":"Horrigan","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.nbd.2025.106871_bb0085","article-title":"miRTarBase: a database curates experimentally validated microRNA-target interactions","volume":"39(Database issue), D163-9","author":"Hsu","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: a review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"23","key":"10.1016\/j.nbd.2025.106871_bb0095","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","article-title":"Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs","volume":"116","author":"Jima","year":"2010","journal-title":"Blood"},{"issue":"D1","key":"10.1016\/j.nbd.2025.106871_bb0100","doi-asserted-by":"crossref","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open Targets: a platform for therapeutic target identification and validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.nbd.2025.106871_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063007","article-title":"Molecular alterations in sporadic and SOD1-ALS immortalized lymphocytes: towards a personalized therapy","volume":"22","author":"Lastres-Becker","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","article-title":"The role of microRNAs in neurodegenerative diseases: a review","volume":"39","author":"Li","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"4","key":"10.1016\/j.nbd.2025.106871_bb0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif.)"},{"key":"10.1016\/j.nbd.2025.106871_bb0120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/1471-2164-12-464","article-title":"Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor","volume":"12","author":"Londin","year":"2011","journal-title":"BMC Genomics"},{"issue":"5\u20136","key":"10.1016\/j.nbd.2025.106871_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","article-title":"A revision of the El Escorial criteria - 2015","volume":"16","author":"Ludolph","year":"2015","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"issue":"7 Suppl","key":"10.1016\/j.nbd.2025.106871_bb0130","first-page":"S104","article-title":"Pathogenesis and presentation of ALS: examining reasons for delayed diagnosis and identifying opportunities for improvement","volume":"29","author":"Lynch","year":"2023","journal-title":"Am. J. Manag. Care"},{"issue":"5","key":"10.1016\/j.nbd.2025.106871_bb0135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2025.106871_bb0140","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.nbd.2025.106871_bb0145","series-title":"WO2005097117A1","author":"Mart\u00ednez Gil","year":"2005"},{"issue":"16","key":"10.1016\/j.nbd.2025.106871_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168975","article-title":"Tideglusib, a non-ATP competitive inhibitor of GSK-3\u03b2 as a drug candidate for the treatment of amyotrophic lateral sclerosis","volume":"22","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2025.106871_bb0155","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"3\u20134","key":"10.1016\/j.nbd.2025.106871_bb0160","first-page":"305","article-title":"Immortalization of human lymphocytes by Epstein-Barr virus","volume":"55","author":"Miller","year":"1982","journal-title":"Yale J. Biol. Med."},{"issue":"2","key":"10.1016\/j.nbd.2025.106871_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/carcin\/bgx126","article-title":"MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective study","volume":"39","author":"Muti","year":"2018","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.nbd.2025.106871_bb0170","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.18632\/oncotarget.15109","article-title":"Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer\u2019s disease patients from non-demented subjects","volume":"8","author":"Nagaraj","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2025.106871_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.nbd.2025.106871_bb0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaneurol.2022.0901","article-title":"Efficacy and safety of ultrahigh-dose methylcobalamin in early-stage amyotrophic lateral sclerosis: a randomized clinical trial","volume":"79","author":"Oki","year":"2022","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2025.106871_bb0185","article-title":"Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms","volume":"11","author":"Pansarasa","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"4","key":"10.1016\/j.nbd.2025.106871_bb0190","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s12035-018-1249-8","article-title":"Recapitulation of pathological TDP-43 features in immortalized lymphocytes from sporadic ALS patients","volume":"56","author":"Posa","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.nbd.2025.106871_bb0195","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/hmg\/ddt008","article-title":"Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis","volume":"22","author":"Prause","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.nbd.2025.106871_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081623","article-title":"Clinical determinants of disease progression in amyotrophic lateral sclerosis-a retrospective cohort study","volume":"10","author":"Requardt","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.nbd.2025.106871_bb0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/biostatistics\/kxm030","article-title":"Small-sample estimation of negative binomial dispersion, with applications to SAGE data","volume":"9","author":"Robinson","year":"2008","journal-title":"Biostatistics (Oxf., Engl.)"},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0210","first-page":"139","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics (Oxf., Engl.)"},{"issue":"5","key":"10.1016\/j.nbd.2025.106871_bb0215","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cge.12117","article-title":"Clinical and genetic heterogeneity of amyotrophic lateral sclerosis","volume":"83","author":"Sabatelli","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2025.106871_bb0220","article-title":"Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis","author":"Sapaly","year":"2024","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.nbd.2025.106871_bb0225","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.nbd.2025.106871_bb0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.neubiorev.2017.01.045","article-title":"The neuropathological signature of bulbar-onset ALS: a systematic review","volume":"75","author":"Shellikeri","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.nbd.2025.106871_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160158","article-title":"Inhibition of vascular endothelial growth factor receptor 2 exacerbates loss of lower motor neurons and axons during experimental autoimmune encephalomyelitis","volume":"11","author":"Stanojlovic","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nbd.2025.106871_bb0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ane.13698","article-title":"Blood biomarkers in ALS: challenges, applications and novel frontiers","volume":"146","author":"Sturmey","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul","year":"2018","journal-title":"Protein Sci."},{"issue":"5\u20136","key":"10.1016\/j.nbd.2025.106871_bb0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.compbiolchem.2007.08.009","article-title":"Workflow based framework for life science informatics","volume":"31","author":"Tiwari","year":"2007","journal-title":"Comput. Biol. Chem."},{"issue":"3","key":"10.1016\/j.nbd.2025.106871_bb0255","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s12035-014-8757-y","article-title":"Role of VEGF and VEGFR2 receptor in reversal of ALS-CSF induced degeneration of NSC-34 motor neuron cell line","volume":"51","author":"Vijayalakshmi","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0260","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad331","article-title":"Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival","volume":"6","author":"Waller","year":"2024","journal-title":"Brain Commun."},{"issue":"12","key":"10.1016\/j.nbd.2025.106871_bb0265","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.15252\/emmm.201606403","article-title":"Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS","volume":"8","author":"Watanabe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.nbd.2025.106871_bb0270","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2217\/bmm-2017-0041","article-title":"Search for Alzheimer\u2019s disease biomarkers in blood cells: hypotheses-driven approach","volume":"11","author":"Wojsiat","year":"2017","journal-title":"Biomark. Med"},{"key":"10.1016\/j.nbd.2025.106871_bb0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omtn.2020.05.023","article-title":"The biogenesis and functions of piRNAs in human diseases","volume":"21","author":"Wu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.nbd.2025.106871_bb0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2019.05.058","article-title":"miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K\/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells","volume":"710","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.nbd.2025.106871_bb0285","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:36:24Z","timestamp":1777602984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":57,"alternative-id":["S0969996125000877"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106871","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106871"}}